Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles

Genes and Immunity

Volumn 3, Issue 2, 2002, Pages 102-106

  Meisel, P ^a   Krause, T ^a   Cascorbi, I ^a   Schroeder, W ^a   Herrmann, F ^a   John, U ^a   Kocher, Th ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Gender; Genetic polymorphism; Myeloperoxidase; Periodontal disease

Indexed keywords

ADENINE; GUANINE; MYELOPEROXIDASE; OXIDOREDUCTASE; SEX HORMONE; PEROXIDASE;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CALCULATION; CIGARETTE SMOKING; CONTROLLED STUDY; DENTAL HEALTH; EDUCATION; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HETEROZYGOSITY; HOMOZYGOSITY; HORMONAL REGULATION; HOST RESISTANCE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOGENESIS; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SOCIOECONOMICS; CROSS-SECTIONAL STUDY; GENETIC PREDISPOSITION; GENETICS; GERMANY; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; ALLELES; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0036547366     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363840     Document Type: Article

References (31)

1. Miyasaki KT, Nemirovskiy E. Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria. Oral Microbiol Immunol 1997; 12: 27-32.
2. Cao CF, Smith QT. Crevicular fluid myeloperoxidase at healthy, gingivitis and periodontitis sites. J Clin Periodontol 1989; 16: 17-20.
3. Altman LC, Baker C, Fleckman P, Luchtel D, Oda D. Neutrophil-mediated damage to human gingival epithelial cells. J Periodontal Res 1992; 27: 70-79.
4. Eley BM, Cox SW. Advances in periodontal diagnosis. 7. Proteolytic and hydrolytic enzymes link with periodontitis. Br Dent J 1998; 184: 323-328..
5. Hofstra AH, Uetrecht JP. Myeloperoxidase-mediated activation of xenobiotics by human leukocytes. Toxicology 1993; 82: 221-242.
6. Uetrecht JP, Shear NH, Zahid N. N-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system. Drug Metab Dispos 1993; 21: 830-834.
7. Trush MA, Seed JL, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radical Biol Med 1991; 10: 201-209.
8. Williams JA, Stone EM, Millar BC, Hewer A, Phillips DH. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts. Mutagenesis 2000; 15: 149-154.
9. Yamalik N, Caglayan F, Kilinc K, Kilinc A, Tumer C. The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status. J Periodontol 2000; 71: 460-467.
10. Austin GE, Lam L, Zaki SR et al. Sequence comparison of putative regulatory DNA of the 5' flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia 1993; 7: 1445-1450.
11. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1- thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271: 14412-14420.
12. Cascorbi I, Henning S, Brockmöller J et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res 2000; 60: 644-649.
13. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57: 5001-5003.
14. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 2000; 21: 1163-1166.
15. Matsuo K, Hamajima N, Shinoda M et al. Possible risk reduction in esophageal cancer associated with MPO -463 A allele. J Epidemiol 2001; 11: 109-114.
16. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. Myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001; 142: 336-339.
17. Hamajima N, Matsuo K, Suzuki T et al. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001; 92: 488-493.
18. Reynolds WF, Rhees J, Maciejewski D et al. Myeloperoxidas polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol 1999; 155: 31-41.
19. Nagra RM, Becher B, Tourtellotte WW et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997; 78: 97-107.
20. Porter W, Saville B, Hoivik D, Safe S. Functional synergy between the transcription factor SP1 and the estrogen receptor. Mol Endocrinol 1997; 11: 1569-1580.
21. Reynolds WF, Hiltunen M, Pirskanen M et al. MPO and APOε4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 2000; 55: 1284-1290.
22. Yamada M, Yoshida M, Hashinaka K. Identification of transcriptional cis-elements in introns 7 and 9 of the myeloperoxidase gene. J Biol Chem 1993; 268: 13479-13485.
23. Jansson G. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes-a possible cause of oxidative stress in inflammatory cells. Free Radical Res Commun 1991; 14: 195-208.
24. Marcozzi FG, Madia F, DelBianco G, Mattei E, deFeo G: Lacrimal fluid peroxidase activity during the menstrual cycle. Curr Eye Res 2000; 20: 178-182.
25. Bekesi G, Kakucs R, Varbiro S et al. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. Br J Obstet Gynaecol 2001; 108: 474-481.
26. Santanam N, Shern-Brewer R, McClatchey R et al. Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res 1998; 39: 2111-2118.
27. Klinger G, Glanzer S, Sigusch B, Klinger G, Romer W. Influence of sexual steroids on cell functions of PMNL in the gingival sulcus. Pharmazie 2000; 55: 678-680.
28. Genco RJ. Current view of risk factors for periodontal disease. J Periodontol 1996; 67: 1041-1049.
29. John U, Greiner B, Hensel E et al. Study of Health in Pomerania (SHIP) - A health examination survey in an east German region: Objectives and design. Soz Praventivmed 2001; 46: 186-194.
30. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2001; 153: 807-814.
31. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 2001; 153: 1016-1020.